%0 Journal Article
%A Dorst, Daphne N
%A Smeets, Esther M M
%A Klein, Christian
%A Frielink, Cathelijne
%A Geijs, Daan
%A Trajkovic-Arsic, Marija
%A Cheung, Phyllis F Y
%A Stommel, Martijn W J
%A Gotthardt, Martin
%A Siveke, Jens T
%A Aarntzen, Erik H J G
%A van Lith, Sanne A M
%T Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma.
%J Molecular pharmaceutics
%V 20
%N 8
%@ 1543-8384
%C Washington, DC
%I American Chemical Society
%M DKFZ-2023-01498
%P 4319-4330
%D 2023
%Z 2023 Aug 7;20(8):4319-4330
%X Patients with pancreatic ductal adenocarcinoma (PDAC) have a dismal 5 year survival of 9
%K cancer-associated fibroblast (CAF) (Other)
%K fibroblast activation protein (FAP) (Other)
%K pancreatic ductal adenocarcinoma (PDAC) (Other)
%K syngeneic models (Other)
%K targeted photodynamic therapy (tPDT) (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:37485886
%R 10.1021/acs.molpharmaceut.3c00453
%U https://inrepo02.dkfz.de/record/277783